News

The study has the ultimate goal of reducing opioid overdose deaths by 40% in participating communities.

The second annual Edward Kremers Seminar in the History of Pharmacy & Drugs continues the conversation surrounding addiction and recovery.

Researchers at the University of Kentucky Center of Excellence in Rural Health (UK CERH) have released the findings of a study conducted to understand possible factors contributing to declining overdose mortality rates in Eastern Kentucky.

The Kentucky Overdose Data 2 Action (OD2A) Community Summit is set for this Thursday, April 29, and has a special emphasis on the types of drugs involved in overdose deaths and the age groups that experienced the greatest increase in deaths.

A number of UK experts will be presenting their work in the field of opioid use disorder research, treatment and prevention this week at the 2021 Rx Drug Abuse and Heroin Summit, held virtually this year due to the ongoing pandemic.

“I’m looking forward to enhancing screening and management of substance use disorders in our primary care practice at the Polk-Dalton Clinic. This will increase access to treatment for many patients, and we will also be able to improve education for our medical students and residents who rotate through the clinic.”

Dr. Okoli received esteemed honor for his outstanding research contributions to developing and evaluating tobacco treatment programs for marginalized populations, particularly individuals living with mental illnesses and substance abuse disorders.

The research team will recruit 800 Black American nonmedical prescription opioid users and interview them to develop an understanding of the characteristics associated with their drug use and treatment use.

Wasp dope is a crystalline substance created by electrifying pyrethroid-containing substances – such as wasp sprays – that may give users a methamphetamine-like “rush.” Recent reports have highlighted the emergence of this new drug as an issue of concern, research into the substance is so far lacking.

To curb overdose deaths, ease the financial burden on health care, and improve patient outcomes, the researchers worked with patients who need tools for recovery from opioid use disorder, such as mental health therapists, relapse-prevention services, and necessary medications.